Recent studies have begun to demonstrate the utility of RNA-seq for identifying mRNA splicing events in breast cancer susceptibility genes, including BRCA1 (Davy et al., 2017; de Jong et al., 2017; Hojny et al., 2017), BRCA2 (Davy et al., 2017), PALB2 (Lopez-Perolio et al., 2019), and BARD1 (Davy et al., 2017). This evidence concerns the gene BARD1 and breast carcinoma.